Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.

Hepatitis C Virus (HCV) is a major public health concern, with no effective vaccines currently available and 3% of the world's population being infected. Despite the existence of both B- and T-cell immunity in HCV-infected patients, chronic viral infection and HCV-related malignancies progress....

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Zhang, Yeuying Liu, Kelly M Moxley, Lucy Golden-Mason, Michael G Hughes, Tongxin Liu, Mirjam H M Heemskerk, Hugo R Rosen, Michael I Nishimura
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-07-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1001018&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236153025789952
author Yi Zhang
Yeuying Liu
Kelly M Moxley
Lucy Golden-Mason
Lucy Golden-Mason
Michael G Hughes
Tongxin Liu
Mirjam H M Heemskerk
Hugo R Rosen
Michael I Nishimura
author_facet Yi Zhang
Yeuying Liu
Kelly M Moxley
Lucy Golden-Mason
Lucy Golden-Mason
Michael G Hughes
Tongxin Liu
Mirjam H M Heemskerk
Hugo R Rosen
Michael I Nishimura
author_sort Yi Zhang
collection DOAJ
description Hepatitis C Virus (HCV) is a major public health concern, with no effective vaccines currently available and 3% of the world's population being infected. Despite the existence of both B- and T-cell immunity in HCV-infected patients, chronic viral infection and HCV-related malignancies progress. Here we report the identification of a novel HCV TCR from an HLA-A2-restricted, HCV NS3:1073-1081-reactive CTL clone isolated from a patient with chronic HCV infection. We characterized this HCV TCR by expressing it in human T cells and analyzed the function of the resulting HCV TCR-transduced cells. Our results indicate that both the HCV TCR-transduced CD4(+) and CD8(+) T cells recognized the HCV NS3:1073-1081 peptide-loaded targets and HCV(+) hepatocellular carcinoma cells (HCC) in a polyfunctional manner with cytokine (IFN-gamma, IL-2, and TNF-alpha) production as well as cytotoxicity. Tumor cell recognition by HCV TCR transduced CD8(-) Jurkat cells and CD4(+) PBL-derived T cells indicated this TCR was CD8-independent, a property consistent with other high affinity TCRs. HCV TCR-transduced T cells may be promising for the treatment of patients with chronic HCV infections.
format Article
id doaj-art-52aa547cdf234f33a0cd08927f35c3f2
institution OA Journals
issn 1553-7366
1553-7374
language English
publishDate 2010-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-52aa547cdf234f33a0cd08927f35c3f22025-08-20T02:02:01ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742010-07-0167e100101810.1371/journal.ppat.1001018Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.Yi ZhangYeuying LiuKelly M MoxleyLucy Golden-MasonLucy Golden-MasonMichael G HughesTongxin LiuMirjam H M HeemskerkHugo R RosenMichael I NishimuraHepatitis C Virus (HCV) is a major public health concern, with no effective vaccines currently available and 3% of the world's population being infected. Despite the existence of both B- and T-cell immunity in HCV-infected patients, chronic viral infection and HCV-related malignancies progress. Here we report the identification of a novel HCV TCR from an HLA-A2-restricted, HCV NS3:1073-1081-reactive CTL clone isolated from a patient with chronic HCV infection. We characterized this HCV TCR by expressing it in human T cells and analyzed the function of the resulting HCV TCR-transduced cells. Our results indicate that both the HCV TCR-transduced CD4(+) and CD8(+) T cells recognized the HCV NS3:1073-1081 peptide-loaded targets and HCV(+) hepatocellular carcinoma cells (HCC) in a polyfunctional manner with cytokine (IFN-gamma, IL-2, and TNF-alpha) production as well as cytotoxicity. Tumor cell recognition by HCV TCR transduced CD8(-) Jurkat cells and CD4(+) PBL-derived T cells indicated this TCR was CD8-independent, a property consistent with other high affinity TCRs. HCV TCR-transduced T cells may be promising for the treatment of patients with chronic HCV infections.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1001018&type=printable
spellingShingle Yi Zhang
Yeuying Liu
Kelly M Moxley
Lucy Golden-Mason
Lucy Golden-Mason
Michael G Hughes
Tongxin Liu
Mirjam H M Heemskerk
Hugo R Rosen
Michael I Nishimura
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
PLoS Pathogens
title Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
title_full Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
title_fullStr Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
title_full_unstemmed Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
title_short Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
title_sort transduction of human t cells with a novel t cell receptor confers anti hcv reactivity
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1001018&type=printable
work_keys_str_mv AT yizhang transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT yeuyingliu transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT kellymmoxley transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT lucygoldenmason transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT lucygoldenmason transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT michaelghughes transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT tongxinliu transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT mirjamhmheemskerk transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT hugorrosen transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity
AT michaelinishimura transductionofhumantcellswithanoveltcellreceptorconfersantihcvreactivity